Press Releases

Feb 15, 2022

Veracyte to Release Fourth Quarter and Full-Year 2021 Financial Results on February 28, 2022

Read More

Feb 14, 2022

New Data Validate Clinical Utility of Veracyte’s Decipher Prostate Genomic Classifier To Help Guide Therapy In Men with Intermediate-Risk Prostate Cancer

Read More

Feb 08, 2022

Veracyte to Participate in 11th Annual SVB Leerink Global Healthcare Conference

Read More

Feb 08, 2022

C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection

Read More

Jan 31, 2022

Veracyte Announces New Data to be Presented at the 2022 ASCO Genitourinary (GU) Cancers Symposium

Read More

Jan 24, 2022

New Data Suggest Veracyte’s Percepta Genomic Sequencing Classifier Can Help Accelerate Timely Treatment for Patients with Early-Stage Lung Cancer

Read More

Jan 10, 2022

C2i Genomics Partners with OncoDNA to Bring AI-Powered Liquid Biopsy for Cancer Diagnostics Across Europe

Read More

Jan 06, 2022

Veracyte Announces Key Leadership Promotions to Advance Its Strategic Global Vision

Read More

Dec 14, 2021

Veracyte Announces Publication of Data Demonstrating Clinical Utility of Its Envisia Genomic Classifier to Improve IPF Diagnosis

Read More

Nov 24, 2021

Veracyte Announces Further European Reimbursement Expansion for Prosigna Breast Cancer Test

Read More